ArticleStem cells international2026

FAP as a Clinical Biomarker: FAP+ CAFs Orchestrate an Immunosuppressive Stem Cell Niche via the COL1A1/2-CD44 Axis in Colon Cancer.

Qian Ding et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.